Iphayini yaselwandle

Umxholo

• Inokwenzeka ukuba isebenze ...
• Kusenokwenzeka ukuba ayisebenzi ...
• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

Imithi yaselwandle yepayini ikhula kumazwe oLwandle lweMeditera. Amaxolo asetyenziselwa ukwenza iyeza. Imithi yepayini yaselwandle ekhula kwindawo esemazantsi-ntshona eFrance isetyenziselwa ukwenza iPycnogenol, igama elibhalisiweyo lorhwebo laseMelika lokufumana isicatshulwa separk bark yaselwandle.

Isicatshulwa se-maritime pine bark sisetyenziselwa i-asthma, ukuphucula ukusebenza kweembaleki, ukusasazeka okungalunganga okunokubangela ukuba imilenze idumbe (ukusilela okungapheliyo kwe-venous okanye i-CVI), kunye nezinye iimeko ezininzi, kodwa kukho ubungqina obunqabileyo besayensi obuxhasa ezinye zezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe IPHINI LOMLAMBO zezi zilandelayo:

Inokwenzeka ukuba isebenze ...

• Isifo sombefu. Ukuthatha isicatshulwa esimiselweyo somthi we-pine bark yonke imihla, kunye namayeza e-asthma, kubonakala ngathi kunciphisa iimpawu zesifuba kunye nemfuno yokuhlangula i-inhalers ebantwaneni nakubantu abadala abane-asthma. Gcina ukhumbule ukuba ulwandle olukhupha i-bark luthathe akufuneki lusetyenziswe endaweni yeyeza lesifuba.
• Ukusebenza kwezemidlalo. Abantu abancinci (abaneminyaka engama-20 ukuya kwengama-35) babonakala bekwazi ukuzivocavoca kwitreadmill ixesha elide emva kokuthatha isicatshulwa esimiselweyo somthi wepayini waselwandle mihla le malunga nenyanga. Kananjalo, uqeqesho lweembaleki kuvavanyo lomzimba okanye itriathlon lubonakala lusebenza ngcono kwiimvavanyo nakukhuphiswano xa bethatha le mveliso mihla le kwiiveki ezisi-8 ngelixa beqeqeshwa.
• Ukujikeleza okungalunganga okunokubangela ukuba imilenze idumbe (ukungoneli okungapheliyo okanye i-CVI). Ukuthatha isicatshulwa esimiselweyo somthi wepine waselwandle ngomlomo kubonakala ngathi kunciphisa umlenze kunye nobunzima, kunye nokugcinwa kolwelo, kubantu abaneengxaki zokujikeleza. Ukusebenzisa le mveliso kunye neesitokisi zokucinezela kubonakala kusebenza ngakumbi kunokusebenzisa izitokisi zokunyanzelisa kuphela. Abanye abantu bakwasebenzisa isicatshulwa sehashe se-chestnut ukunyanga le meko, kodwa ukusebenzisa i-pine bark extract kubonakala kusebenza ngakumbi.

Kusenokwenzeka ukuba ayisebenzi ...

• Cholesterol ephezulu. Ubungqina obuninzi bubonisa ukuba isicatshulwa esimiselweyo separk bark yaselwandle asisihlisi "cholesterol embi" (low-density lipoprotein (LDL) cholesterol) kubantu abane-cholesterol ephezulu.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Yehla kwimemori nakwizakhono zokucinga ezenzeka ngesiqhelo ngobudala. Uninzi lophando kubantu abakhulileyo abasempilweni abafumananga nzuzo okanye izakhono zokucinga emva kokuthatha isicatshulwa esisemgangathweni sexolo yasolwandle.
• Ukuqina kwemithambo (atherosclerosis). Kukho ubungqina bokuba ukuthatha isicatshulwa esisemgangathweni se-pine bark kathathu yonke imihla kwiiveki ezi-4 kunokunceda ukuphucula ezinye iingxaki ezibangelwa kukuqina kwemithambo.
• Ukuqwalaselwa kwentsilelo-yokuchaphazeleka kwengqondo (ADHD). Ukuthatha isicatshulwa esimiselweyo somthi wepine waselwandle ngomlomo akubonakali ngathi kunceda iimpawu ze-ADHD kubantu abadala. Nangona kunjalo, ukuyithatha ngomlomo inyanga enye kubonakala ngathi kuphucula iimpawu kubantwana.
• Isifo esinqabileyo esibandakanya izilonda ezinzima emlonyeni nakwezinye iindawo zomzimba (Behcet syndrome). Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark kuphucula iimpawu kubantu abane-Behcet syndrome.
• Iprostate eyandisiweyo (benign prostatic hyperplasia okanye iBPH). Uphando lwakwangoko lwafumanisa ukuba ukuthatha isicatshulwa esimiselweyo separk bark yolwandle kunxulunyaniswa nokukwazi okungcono ukuchama kubantu abane-BPH.
• Imemori kunye nezakhono zokucinga (umsebenzi wokuqonda). Uphando lwakwangoko lwafumanisa ukuba ukuthatha isicatshulwa esimiselweyo somthi wepine waselwandle ngomlomo kuphucula ukusebenza kwengqondo kunye nememori kubantu abadala. Kukwabonakala ngathi kuphucula kancinci amanqaku ovavanyo kubafundi beekholeji.
• Ukuhla kwenkumbulo kunye nezakhono zokucinga kubantu abadala ezingaphezulu kokuqhelekileyo kubudala babo. Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark kuphucula ukusebenza kwengqondo kubantu abadala abanokukhubazeka kwengqondo okuthobekileyo.
• Okubandayo Okunye. Uphando lwakwangoko lwafumanisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark ngomlomo kabini yonke imihla ukuqala ekuqaleni kwengqele kubonakala kunciphisa inani leentsuku ngengqele kwaye. Ikwanokunciphisa inani leemveliso ezibandayo ezingaphaya kwekhawuntare ezifunekayo ukulawula iimpawu.
• Ipleyiti yamazinyo. Uphando lwakwangoko lubonisa ukuba ukuhlafuna ubuncinci iziqwenga ze-6 zentshungama kunye nencindi eyongeziweyo kwi-bark ye-pine bark kangangeentsuku ezili-14 kunciphisa ukopha kwaye kuthintela ukwanda kwamatye.
• Seswekile. Ubungqina bokuqala buchaza ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark yonke imihla kwiiveki ezi-3 ukuya kwezi-12 kunciphisa iswekile yegazi kubantu abanesifo seswekile.
• Izilonda ezinyaweni kubantu abanesifo seswekile. Uphando lwakwangoko lubonisa ukuba ukuthatha i-pine bark ekhutshwe ngomlomo kunye nokuyisebenzisa kulusu kunceda ukuphilisa izilonda ezinyaweni ezinxulumene nesifo seswekile.
• Isifo semithambo yegazi encinci kubantu abanesifo seswekile (isifo seswekile). Uphando lwakwangoko lubonisa ukuba ukuthatha i-bark yolwandle esemgangathweni yolwandle kukhutshwa kathathu mihla le kwiiveki ezi-4 kuphucula ukujikeleza kunye neempawu kubantu abanesifo seswekile.
• Umbono weengxaki kubantu abanesifo seswekile (isifo seswekile). Ukuthatha isicatshulwa esimiselweyo sepine bark ngomlomo iinyanga ezi-2 kubonakala ngathi kucotha okanye ukuthintela ukuqhubekeka ngokuqatha kwesifo se-retinal esibangelwa sisifo seswekile, isifo sokuqina kwemithambo yegazi, okanye ezinye izifo. Kukwabonakala ngathi kuphucula ukubona kwamehlo.
• Umlomo owomileyo. Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esimiselweyo somthi wepayini waselwandle kunye namathe angenziwa kuphucula ukoma komlomo okungcono kunamathe ayinyani kuphela.
• Ukungasebenzi kakuhle kwe-Erectile (ED). Uphando lwakwangoko lucebisa ukuba ukukhutshwa komthi wepine bark okumiselweyo, kusetyenziswa yedwa okanye ngokudibeneyo ne-L-arginine, kunokuphucula ukusebenza ngokwesondo kumadoda ane-ED. Kubonakala ngathi kuthatha iinyanga ezi-3 zonyango ukuze ziphuculwe.
• Yewena mkhuhlane. Olunye uphando lubonisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark ngaphambi kokuqala kwexesha lokungabikho komzimba kunciphisa iimpawu zokungabikho komzimba kubantu abane-birch allergies.
• Iimpawu. Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esimiselweyo somthi wepine waselwandle ngomlomo, uwedwa okanye ngokudibeneyo nekhrimu enesicatshulwa esifanayo, kuphucula umgangatho wobomi kunye neempawu zehemorrhoids. Olunye uphando lubonisa ukuba ukuthatha le nto ikhutshwe ngomlomo kunokuphucula iimpawu ze-hemorrhoids kwabasetyhini emva kokubeleka.
• Igazi elonyukayo. Olunye uphando lubonisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark kunokunciphisa uxinzelelo lwegazi. Kodwa olunye uphando alubonisanga siphumo.
• Ingxaki yexesha elide yamathumbu amakhulu ebangela iintlungu zesisu (isifo esiswini esinokucaphuka okanye i-IBS). Uphando lwakwangoko lwafumanisa ukuba ukuthatha isicatshulwa esimiselweyo separk bark yaselwandle kunokunciphisa iintlungu zesisu, iicramps, kunye nokusetyenziswa kwamayeza kubantu abane-IBS.
• Ijet lag. Uphando lwakwangoko lwafumanisa ukuba ukuthatha isicatshulwa esimiselweyo somthi wepine waselwandle, ukuqala kwiintsuku ezingama-2-3 ngaphambi kokubhabha ngenqwelomoya, kungalinciphisa ixesha ezenzeka ngalo iimpawu ze-jet lag kunye nokunciphisa iimpawu ze-jet lag.
• Iintlanzi zomlenze. Kukho ubungqina bokuba ukuthatha isicatshulwa esimiselweyo separk bark yaselwandle ngomlomo yonke imihla kunokunciphisa iicramps zomlenze.
• Ingxaki yendlebe yangaphakathi ephawulwe ngumdaka, ukulahlekelwa kwindlebe, kunye nokukhala kwindlebe (isifo seMeniere). Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark kunokunciphisa ukukhala ezindlebeni kunye neempawu ngokubanzi kubantu abadala abanesifo sikaMeniere.
• Iimpawu zokuyeka ukuya exesheni. Uphando lwakwangoko lafumanisa ukuba ukuthatha isicatshulwa esimiselweyo separk bark yolwandle ngomlomo kunciphisa iimpawu ze-menopausal, kubandakanya ukudinwa, intloko ebuhlungu, uxinzelelo kunye noxinzelelo kunye nokukhanya okutshisayo.
• Ukuhlelwa kweempawu ezonyusa umngcipheko wesifo seswekile, isifo sentliziyo, kunye nokubetha (isifo se-metabolic syndrome). Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark ngomlomo kathathu ngemini kangangeenyanga ezi-6 kunciphisa i-triglycerides, amanqanaba eswekile yegazi, kunye noxinzelelo lwegazi, kunye nokunyusa i-lipoprotein ("elungileyo" okanye i-HDL) ye-cholesterol ephezulu kubantu abane-metabolic syndrome .
• Ukudumba (ukudumba) kunye nezilonda ngaphakathi emlonyeni (i-mucositis yomlomo). Ukufaka isicelo sesisombululo esine-standardised extract of maritime pine bark ngaphakathi emlonyeni iveki enye kubonakala ngathi kunceda ukuphilisa izilonda zomlomo ebantwaneni nakwishumi elivisayo abafumana unyango lwe-chemotherapy.
• Osteoarthritis. Kukho ubungqina obuxubeneyo malunga nokusebenza kwepine yaselwandle yeorethrosis. Ukuthatha isicatshulwa esimiselweyo separk bark yaselwandle ngomlomo kunokunciphisa iimpawu, kodwa kubonakala ngathi ayinciphisi zintlungu okanye kuphucula amandla okwenza imisebenzi yemihla ngemihla. Uphando lwakwangoko lufumanise ukuba ukusebenzisa ii-patches ngokukhutshwa komgangatho we-pine bark kulusu kunokunciphisa iintlungu kubantu abane-osteoarthritis emadolweni.
• Isifo seParkinson. Uphando lwakwangoko lufumanise ukuba ukuthatha isicatshulwa esimiselweyo separk bark yaselwandle kunye nonyango lwe-levodopa / carbidopa kuphucula ukungcangcazela kunye nezinye iimpawu zomzimba. Ikwabonakala ngathi iphucula ukusebenza kwengqondo.
• Ubuhlungu kwabasetyhini abakhulelweyo. Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esimiselweyo sepayini yaselwandle ngomlomo yonke imihla kwiinyanga ezi-3 zokugqibela zokukhulelwa kunciphisa iintlungu ezisezantsi, iintlungu zethambo, iintlungu zentlungu, kunye nentlungu ngenxa yemithambo ye-varicose okanye itampu yenkomo.
• Iintlungu zepelvic kwabasetyhini. Kukho ubungqina bokuqala bokuba ukuthatha isicatshulwa esimiselweyo separk bark yaselwandle ngomlomo kunokunceda ukunciphisa iintlungu zesisu kubafazi abane-endometriosis okanye iicramps ezinzima.
• I-Scaly, isikhumba esilumkileyo (psoriasis). Uphando lwakwangoko lwafumanisa ukuba ukuthatha isicatshulwa esimiselweyo somthi wepine waselwandle ngomlomo kunganciphisa ubungakanani bamacwecwe esikhumba, kuphuculwe umgangatho wobomi, kwaye kunciphise ukusetyenziswa kwe-steroids kubantu abane-psoriasis.
• Ukuphendula kabuhlungu kubanda ngakumbi kwiminwe neenzwane (iRaynaud syndrome). Uphando lwakwangoko lwafumanisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark kunokuphucula ukubanda kunye nentlungu kwiminwe kubantu abakule meko.
• Ukulahleka kwemisipha okunxulumene nobudala (sarcopenia). Uphando lwakwangoko lwafumanisa ukuba ukuthatha isicatshulwa esimiselweyo somthi wepine waselwandle ngomlomo kuphucula ukusebenza kwemisipha kubantu abadala abanempawu zokulahleka kwemisipha.
• Ukuphazamiseka okuzenzekelayo apho amadlala avelisa iinyembezi kunye namathe onakaliswe (Sjogren syndrome). Uphando lwakwangoko kubantu abane-Sjogren syndrome lufumanise ukuba ukuthatha isicatshulwa esimiselweyo sepine bark ngomlomo kunciphisa iimpawu zamehlo owomileyo kunye nomlomo owomileyo. Ikwanokunciphisa isidingo samayeza athile.
• Isifo sokuzimela komzimba esibangela ukudumba okubanzi (inkqubo lupus erythematosus okanye SLE). Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark ngomlomo kunciphisa iimpawu ze-SLE kwezinye izigulana.
• Ukukhala ezindlebeni (tinnitus). Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esisemgangathweni se-pine bark kunciphisa ukukhala ezindlebeni.
• Iimvumba ze-Varicose. Uphando lwakwangoko lubonisa ukuba ukuthatha isicatshulwa esimiselweyo separk bark yaselwandle kunokunciphisa ukukrala kwemilenze, ukudumba kwemilenze, kunye nenani lemithambo ye-varicose kunye nemithambo yesigcawu kubafazi emva kokubeleka.
• Amahlwili egazi enza emithanjeni (venous thromboembolism okanye VTE). Ukuthatha i-marine ethile ye-pine bark ikhuphe yodwa ngaphambi nasemva kwendiza ende kubonakala ngathi ayithinteli amahlwili egazi kubantu abasemngciphekweni omkhulu. Kodwa kunokunciphisa umngcipheko we-post-thrombotic syndrome. Le meko inokukhula kubantu abasele benengubo yegazi.
• Ukumelwa yintliziyo.
• Ukukhathazeka kwemisipha.
• Iingxaki ngokusebenza ngokwesondo.
• Uthintelo ukubetha.
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala i-pine yaselwandle kwezi zinto zisetyenziswayo.

Ipayini yaselwandle iqulethe izinto ezinokuphucula ukuhamba kwegazi. Inokuvuselela amajoni omzimba, ukunciphisa ukudumba, ukuthintela usulelo, kunye nefuthe le-antioxidant.

Xa kuthathwa ngomlomoIsicatshulwa esimiselweyo somthi wepine wolwandle (iPycnogenol, uPhando lweHorphag) ngu UKHUSELEKO OLUNOKWENZEKA kwiidosi ze-50-450 mg yonke imihla ukuya kunyaka omnye. Ingabangela ukuba nesiyezi, iingxaki zesisu, intloko ebuhlungu, izilonda zomlomo, kunye nomphunga ombi.

Xa isetyenziswa eluswiniIsicatshulwa esimiselweyo somthi wepine wolwandle (iPycnogenol, uPhando lweHorphag) ngu UKHUSELEKO OLUNOKWENZEKA njengekhrimu ukuya kwiintsuku ezisi-7 okanye njengomgubo kangangeeveki ezi-6.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Uphando lwakwangoko lubonisa ukuba isicatshulwa esimiselweyo separk bark yaselwandle (iPycnogenol, Uphando lweHorphag) UKHUSELEKO OLUNOKWENZEKA xa isetyenziselwa ukukhulelwa emva kwexesha. Nangona kunjalo, de kube kwaziwa ngakumbi, kufuneka isetyenziswe ngononophelo okanye ithintelwe ngabafazi abakhulelweyo.

Akukho lwazi lwaneleyo lwaneleyo malunga nokhuseleko lokuthatha iimveliso zepayini yolwandle ukuba uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

AbantwanaIsicatshulwa esimiselweyo somthi wepine wolwandle (iPycnogenol, uPhando lweHorphag) ngu UKHUSELEKO OLUNOKWENZEKA xa kuthathwa ngomlomo, ixesha elifutshane.

"Izifo zokuzikhusela komzimba" ezinjenge-multiple sclerosis (MS), lupus (systemic lupus erythematosus, SLE), isifo samathambo (RA), okanye ezinye iimeko: I-pine yaselwandle inokubangela ukuba amajoni omzimba asebenze ngakumbi, kwaye oku kunokonyusa iimpawu zezifo ezikhuselayo. Ukuba unayo enye yezi meko, kungcono ungazisebenzisi iipayini zaselwandle ..

Iimeko zokophaKwithiyori, amanani aphakamileyo opayini waselwandle anokunyusa umngcipheko wokopha kubantu abaneemeko zokopha.

SeswekileKwithiyori, iidosi eziphezulu zephayini yaselwandle inokunciphisa iswekile yegazi kakhulu kubantu abanesifo seswekile.

HepatitisKwithiyori, ukuthatha ipayini yaselwandle kunokubangela ukuba isibindi sisebenze ngakumbi kubantu abane-hepatitis.

Ugqirha: Imayine yaselwandle inokuthi icothe ukujiya kwegazi kunye nokunciphisa iswekile egazini. Kukho inkxalabo enokubangela ukuba iswekile esegazini iye ezantsi kakhulu kwaye inyuse ithuba lokopha ngexesha nasemva kotyando. Yeka ukusebenzisa ipayini yaselwandle ubuncinci iiveki ezi-2 ngaphambi kotyando olucwangcisiweyo.

Iphakathi

Lumka ngale nhlanganisela.

Amayeza eswekile (iziyobisi zeAntidiabetes)

Ipayini yaselwandle inokunciphisa amanqanaba eswekile yegazi. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ukuthatha ipayini yaselwandle kunye namayeza eswekile kunokubangela ukuba iswekile yegazi yakho ibe sezantsi kakhulu. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.

Amanye amayeza asetyenziselwa isifo seswekile afaka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), kunye nezinye. Indlela yokusebenza ayicacanga.

Amayeza anciphisa amajoni omzimba (i-Immunosuppressants)

Ipayini yaselwandle ibonakala inyusa amajoni omzimba. Ngokwandisa amajoni omzimba, ipayini yaselwandle inokunciphisa ukusebenza kwamayeza anciphisa amajoni omzimba.

Amanye amayeza anciphisa amajoni omzimba abandakanya i-azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf ), Sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids) kunye nabanye.

Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)

Ipayini yaselwandle inokuthi icothise ukujiya kwegazi. Ukuthatha ipayine yaselwandle kunye namayeza acothisa ukucola kunokunyusa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukujiya kwegazi aquka iasprini, clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), warfarin (Coumadin), kunye nezinye.

Iherbs kunye nezongezo ezinokunciphisa iswekile yegazi

Ipayini yaselwandle inokunciphisa amanqanaba eglucose egazini. Ukuyisebenzisa ngamanye amayeza okanye izongezo ezinefuthe elifanayo kunokubangela amanqanaba eswekile yegazi ukuba awe phantsi kakhulu. Amanye amayeza kunye nezongezo ezinokuhlisa iswekile yegazi zibandakanya i-alpha-lipoic acid, i-chromium, i-devil's claw, i-fenugreek, igalikhi, i-guar gum, i-chestnut yehashe, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, nezinye.

Iherbs kunye nezongezo ezinokucothisa igazi

Sebenzisa ipayini yaselwandle kunye namayeza anokucothisa ukujiya kwegazi kunokunyusa umngcipheko wokopha kwabanye abantu. La mayeza afaka i-angelica, i-clove, i-danshen, igalikhi, ijinja, iginkgo, iPanax ginseng, kunye nabanye.

Akukho kunxibelelana kwaziwayo nokutya.

La machiza alandelayo afundwe kuphando lwezesayensi:

ABADALA

NGOMLOMO:

• Isifo sombefuI-1 mg yesitayile somgangatho wepayini waselwandle esimiselweyo esikiti nganye yesisindo somzimba, ukuya kuthi ga kwi-200 mg / ngosuku, sinikwe ngeedosi ezimbini ezahlulwe ngenyanga enye. Kwakhona, i-50 mg yesicatshulwa esifanayo isetyenziswe kabini imihla ngemihla kwiinyanga ezi-6.
• Ukusebenza kwezemidlaloI-100-200 mg isicatshulwa somgangatho wompayini waselwandle osetyenzisiweyo usetyenzisiwe mihla le kwiinyanga ezi-1-2.
• Ukujikeleza okungalunganga okunokubangela ukuba imilenze idumbe (ukungoneli okungapheliyo okanye i-CVI): I-45-360 mg yokukhutshwa komgangatho we-pine bark esemgangathweni ithathiwe yonke imihla ukuya kuthi ga kwiidosi ezintathu ezahlulwe iiveki ezi-3 ukuya kwezi-12.

ABANTWANA

NGOMLOMO:

• Isifo sombefuI-1 mg yesitayile somthi sepayini eselwandle esimiselweyo esikiti nganye yesisindo somzimba sithathiwe ngeedosi ezimbini ezahlulwe iinyanga ezi-3 ngabantwana nakwishumi elivisayo abaneminyaka eyi-6-18.

I-Tannins, i-decorce de Pin, i-orcorce de Pin Maritime, i-Extrit d'Écorce de Pin, i-French Marine Pine Bark Extract, i-French Maritime Pine Bark Extract, i-Leucoanthocyanidins, i-Maritime Bark Extract, i-Oligomères de Procyanidine, i-Oligomères Procyanidericos, , PCO, PCOs, Pine Bark, Pine Bark Extract, Pinus pinaster, Pinus maritima, Proanthocyanidines Oligomériques, Procyanidin Oligomers, Procyanodolic Oligomers, Pycnogenol, Pycnogénol, Pygenol, Tannins Condensés.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. I-Aldret RL, iBellar D. Ukuphinda-phinda ukungaboni, ukuFundisisa ukuPhononongwa kweZiphumo zeParine yePine yokuSebenza ngokuSebenza kunye nokuDumba koPhumo, uxinzelelo lwe-oxidative, ukukhathazeka kwemisipha kunye nomonakalo. J Ukutya ukutya. 2020; 17: 309-20. Jonga i-abstract.
2. UCesarone MR, Belcaro G, Agus GB, et al. Ukungoneliseki okungapheliyo kunye ne-microangiopathy yemithambo: ulawulo ngoxinzelelo kunye nePycnogenol®. IMinerva Cardioangiol. Ngo-2019; 67: 280-7. Jonga i-abstract.
3. U-Hu S, uHosoi M, uBelcaro G, et al. Ulawulo lwe-Raynaud Syndrome emnene, ephambili: ukuxhaswa kunye nePycnogenol®. IMinerva Cardioangiol. Ngo-2019; 67: 392-8. Jonga i-abstract.
4. UCesarone MR, uBelcaro G, uHosoi M, et al. Ulawulo olongezelelekileyo kunye nePycnogenol® kwisifo sikaParkinson ukukhusela ukuphazamiseka kwengqondo. J Neurosurg Sci. Ngo-2020; 64: 258-62. Jonga i-abstract.
5. UVinciguerra G, uBelcaro G, uFeragalli B, et al. IPycnoRacer®, isiselo sokomelela komzimba kubandakanya iPycnogenol®, iphucula ukubuyela kwimeko yesiqhelo kunye noqeqesho kuvavanyo lweCooper. IPanminerva Med 2019; 61: 457-63. Jonga i-abstract.
6. UBelcaro G, uCesarone MR, uCornelli U, et al. I-Xerostomia: uthintelo ngePycnogenol® supplementation: isifundo somqhubi. IMinerva Stomatol. 2019; 68: 303-7. Jonga i-abstract.
7. UCesarone MR, uBelcaro G, uSpipione C, et al. Ukuchaneka Ukuthintela ukoma kwilungu lobufazi kubafazi be-perimenopausal. Ukongezwa kunye neLady Prelox®. UMinerva Ginecol. Ngo-2019; 71: 434-41. Jonga i-abstract.
8. UPourmasoumi M, Hadi A, Mohammadi H, uRouhani MH. Iziphumo zokuxhaswa kwepycnogenol kuxinzelelo lwegazi: Ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwemeta kuvavanyo lweklinikhi. Phytother Res. Ngo-2020; 34: 67-76. Jonga i-abstract.
9. UFogacci F, Tocci G, Sahebkar A, Presta V, Banach M, Cicero AFG. Iziphumo zePycnogenol kuXinzelelo lwegazi: Iziphumo ezivela kuPhononongo oluCwangcisiweyo lweNkqubo ye-PRISMA kunye noVavanyo lweMeta yoHlolo oluLungelelanisiweyo, oluyimfama, uLawulo lwePlacebo, iZifundo zeKlinikhi. I-Angiology. Ngo-2020; 71: 217-25. Jonga i-abstract.
10. I-Smetanka A, i-Stara V, i-Farsky I, i-Tonhajzerova I, i-Ondrejka I. I-Pycnogenol yokuncedisa njengonyango lokunyanga ukungasebenzi koxinzelelo ngokwesondo. Umzimba Int. 2019; 106: 59-69. Jonga i-abstract.
11. ULuzzi R, uBelcaro G, uHu S, et al. Ukusebenza kokuncediswa kwePycnogenol kwizigaba zokuxolelwa kweSjögren syndrome. IMinerva Cardioangiol. 2018; 66: 543-546. ikhonkco: 10.23736 / S0026-4725.18.04638-8. Jonga i-abstract.
12. ULedda A, uBelcaro G, uFeragalli B, okqhubekayo. I-Benign prostatic hypertrophy: Ukuxhaswa kwePycnogenol kuphucula iimpawu zeprotate kunye nevolumu yesinyi eshiyekileyo. IMinerva Med. Ngo-2018; 109: 280-284. Jonga i-abstract.
13. U-Hu S, uBelcaro G, uLedda A, et al. Isifo seBehçet: Iziphumo zokuncedisa iPycnogenol ngexesha lezigaba zokuhlehla. IMinerva Cardioangiol. 2018; 66: 386-390. Jonga i-abstract.
14. UHadi A, uPourmasoumi M, Mohammadi H, Javaheri A, uRouhani MH. Impembelelo yokuxhaswa kwepycnogenol kwiiplasma lipids ebantwini: Ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwemeta yezilingo zeklinikhi. Phytother Res. Ngo-2019; 33: 276-287. Jonga i-abstract.
15. UFeragalli B, uDugall M, uLuzzi R, et al. I-Pycnogenol: ulawulo olongezelelekileyo lwe-osteoarthritis enomqondiso kunye nesiziba. Uphononongo lobhaliso lokujonga. IMinerva Endocrinol. 2019; 44: 97-101. Jonga i-abstract.
16. UBelcaro G, uDugall M, uHu S, et al. Ukuchaneka Ukuthintela ukuphindaphinda kwe-venous thrombosis kunye ne-post-thrombotic syndrome. IMinerva Cardioangiol. Ngo-2018; 66: 238-245. Jonga i-abstract.
17. UBelcaro G, uCornelli U, uDugall, M, uHosoi M, uCotllese R, uFeragalli B.Ukuhamba ngenqwelomoya, i-edema, kunye neminyhadala ye-thrombotic: uthintelo lwezitokisi kunye nokuxhaswa kwePycnogenol (LONFLIT Registry Study). IMinverva Cardioangiologica. Ngo-2018 Epreli; 66: 152-9. Jonga i-abstract.
18. U-Ezzikouri S, uNishimura T, uKohara M, et al. Iziphumo zokuthintela iPycnogenol kwi-hepatitis C yokuphindaphindeka kwentsholongwane. Intsholongwane. Ngo-2015 uJan; 113: 93-102. Jonga i-abstract.
19. UBelcaro G, uLuzzi R, uHu S, et al. Ukuphuculwa kweempawu kunye neempawu kwizigulana ze-psoriasis ezinezongezo zePycnogenol. IPanminerva Med. Ngo-2014 ngoMatshi; 56: 41-8. Jonga i-abstract.
20. UBelcaro G, uGizzi G, uPellegrini L, et al. IPycnogenol kwiimpawu zasemva kokubeleka ezinesifo. UMinerva Ginecol. NgoFebruwari 2014; 66: 77-84. Jonga i-abstract.
21. UBelcaro G, uDugall M, uHosol M, et al. Ukuchaneka I-Pycnogenol kunye ne-centella asiatica yokuqhubela phambili kwe-asymptomatic atherosclerosis. Int Angiol. NgoFebruwari 2014; 33: 20-6. Jonga i-abstract.
22. Ikuyama S, uFan B, uGu J, uMukae K, uWatanabe H.Umatshini weMolekyuli yokuqokelelwa kwe-lipid ye-intracellular: isiphumo sokucinezelwa kwePycnogenol kwiiseli zesibindi. Ukutya okusebenzayo kwiMpilo kunye nezifo 203; 3: 353-364.
23. ULuzzi R, uBelcaro G, uHu S, et al. Ukuphuculwa kweempawu kunye nokuhamba kwe-cochlear kunye nePycnogenol kwizigulana ezinesifo sikaMeniere kunye ne-tinnitus. IMinerva Med. Ngo-2014 uJuni; 105: 245-54. Jonga i-abstract.
24. UBelcaro G, uCesarone R, uSteigerwalt J, et al. Ukuchaneka I-jet-lag: uthintelo ngePycnogenol. Ingxelo yokuqala: uvavanyo kubantu abasempilweni nakwizigulana ezixinzelelekileyo. IMinerva Cardioangiol. I-2008 Okt; 56 (5 iSuppl): 3-9. Jonga i-abstract.
25. IMatsumori A, iHiguchi H, iShimada M.Ifrench marine yipine bark isicatshulwa sithintela ukuphindaphindeka kwentsholongwane kwaye kuthintela ukukhula kwe-myocarditis yentsholongwane. J Card iyasilela. NgoNovemba 2007; 13: 785-91. Jonga i-abstract.
26. I-Belcaro G, i-Luzzi R, i-Dugall M, i-Ippolito E, i-Saggino A. I-Pycnogenol iphucula ukusebenza kwengqondo, ingqwalaselo, ukusebenza kwengqondo kunye nezakhono ezithile zobungcali kwiingcali ezinempilo ezineminyaka eyi-35-55. J Neurosurg Sci. NgoDisemba ka-2014; 58: 239-48. Jonga i-abstract.
27. USarikaki V, uRallis M, u-Tanojo H, et al. In vitro percutaneous absorption of pine bark extract (Pycnogenol) kulusu lomntu. J Ityhefu 2004; 23: 149-158.
28. ULuzzi R, uBelcaro G, uHosoi M, et al. Ukulungelelaniswa kwemingcipheko yentliziyo kwi-pre-menopausal kwabasetyhini abanePycnogenol. UMinerva Ginecol. NgoFebruwari 2017; 69: 29-34. Jonga i-abstract.
29. IiValls RM, uLlaurado E, uFernandez-Castillo S, et al. Iziphumo zobunzima beemolekyuli ezisezantsi ze-procyanidin etyebileyo kwi-bark yase-France yolwandle kwisifo sentliziyo kwimingcipheko ye-1 yezifundo ezixinzelelekileyo: i-randomized, i-blind-blind, i-crossover, i-placebo-controlled trial trial. Unyango lwezonyango. Ngo-2016 uNov 15; 23: 1451-61. Jonga i-abstract.
30. UHosoi M, uBelcaro G, uSaggino A, uLuzzi R, uDugall M, uFeragalli B.Ukuncediswa kwePycnogenol kukungasebenzi kakuhle kwengqondo. J Nuerosurg Sci. NgoJanuwari 2018; 62: 279-284. Jonga i-abstract.
31. UBelcaro G, uDugall M, Ippolito E, Hus S, uSaggino A, uFeragalli B. Isifundo seCOFU3. Ukuphuculwa kokusebenza kwengqondo, ingqalelo, ukusebenza kwengqondo kunye nePycnogenol kwizifundo ezisempilweni (55-70) ngoxinzelelo oluphezulu lwe-oxidative. J Neurosurg Sci 2015 Dis; 59: 437-46.
32. I-Belcaro G, i-Dugall M.Ukulondolozwa kobunzima bemisipha kunye namandla kwizifundo zabantu abadala ngePycnogenol supplementation. IMinerva Ortopedica e Traumatologica 2016 Septemba; 67: 124-30.
33. UBelcaro G, uDugall M, uLuzzi R, Ippolito E, uCesarone MR. I-postpartum varicose veins: ukuxhaswa nge-pycnogenol okanye ukunyanzeliswa kwe-elastic-Ukulandelwa kweenyanga ezili-12. Int J Angiol. Ngo-2017 Mar; 26: 12-19. Jonga i-abstract.
34. UBelcaro G, uGizzi G, uPellegrini L, et al. Uncedo lwePycnogenol luphucula ukulawulwa kweempawu zesifo samathumbu. IPanminerva Med. NgoJanuwari 2018; 60: 65-89. Jonga i-abstract.
35. I-Belcaro G. Uthelekiso lweklinikhi lwe-pycnogenol, i-antistax, kunye nokugcina ukungoneliseki okungapheliyo. Int J Angiol. NgoDisemba ka-2015; 24: 268-74. Epub 2015 Jul 15. Jonga i-abstract.
36. Irhafu: IPinus pinaster Aiton. Inkqubo yeSizwe yeSityalo seGermplasm yaseU.S. Ifumaneka kwi: https://npgsweb.ars-grin.gov/gringlobal/taxonomydetail.aspx?28525. Kufumaneka ngo-Meyi 29, 2018.
37. UVinciguerra G, uBelcaro G, uBonanni E, et al. Ukuvavanywa kweziphumo zokuncedisa ngePycnogenol malunga nokuqina kwizifundo eziqhelekileyo noVavanyo loMzimba loLungiso loMzimba nakwimidlalo yeembaleki kwimizuzu eyi-100 yetrayithloni. J Sports Med Fitness Fitness 2013; 53: 644-54. Jonga i-abstract.
38. I-Sahebkar A. Ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwemeta yeziphumo zepycnogenol kwiiplasma lipids. J Cardiovasc Pharmacol Ther 2014; 19: 244-55. Jonga i-abstract.
39. UKhurana H, Pandey RK, Saksena AK, Kumar A. Uvavanyo lwevithamini E kunye ne-pycnogenol kubantwana abaphethwe ngumlomo womlomo ngexesha lesifo somhlaza. I-Oral Dis 2013; 19: 456-64.
40. UBottari A, uBelcaro G, uLedda A, et al. ILady Prelox iphucula ukusebenza ngokwesondo kwabafazi ngokubanzi abasempilweni ngexesha lokuzala. IMinerva Ginecol 2013; 65: 435-44. Jonga i-abstract.
41. UBelcaro G, uShu H, uLuzzi R, et al. Ukuphuculwa kwengqele eqhelekileyo kunye nePycnogenol: isifundo sobhaliso sasebusika. IPanminerva Med 2014; 56: 301-8. Jonga i-abstract.
42. UBelcaro G, uDugall M, uLuzzi R, uHosoi M, uCorsi M.Uphuculo lwethoni ye-venous kunye ne-pycnogenol kukungoneliseki okungapheliyo: isifundo se-ex vivo kumacandelo e-venous. I-Int J Angiol 2014; 23: 47-52. Jonga i-abstract.
43. UBelcaro G, uCornelli U, uLuzzi R, et al. Uncedo lwePycnogenol luphucula umngcipheko wezempilo kwizifundo ezinesifo se-metabolic syndrome. I-Phytother Res 2013; 27: 1572-8. Jonga i-abstract.
44. Asmat U, Abad K, Ismail K. Iswekile kunye noxinzelelo lwe-oxidative-uphononongo olufutshane. I-Saudi Pharma J 2015. Iyafumaneka kwi: http://dx.doi.org/10.1016/j.jsps.2015.03.013.
45. IMaritim AC, iSanders RA, iWatkins JB 3rd. Iswekile, uxinzelelo lwe-oxidative, kunye nee-antioxidants: uphononongo. J Biochem Mol Toxicol 2003; 17: 24-38 (PubMed) (Umnqamlezo) Jonga i-abstract.
46. UFarid R, uMirfeizi Z Mirheidari M Z Rezaieyazdi Mansouri H Esmaelli H.Ukuncedisa iPycnogenol® kunciphisa iintlungu nokuqina kwaye kuphucula ukusebenza komzimba kubantu abadala abaneedolo osteoarthritis. Uphando ngezondlo 2007; 27: 692-697.
47. URoseff SJ, uGulati R. Ukuphuculwa komgangatho wesidoda yi-pycnogenol. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 33-36.
48. UDurackova, B. Trebatický V. Novotný I. Žit®anová J. Breza. I-Lipid metabolism kunye nokuphuculwa komsebenzi we-Pycnogenol®, ukukhutshwa kwi-bark ye-Pinus pinaster kwizigulana ezinengxaki yokungasebenzi kakuhle kwe-erectile-isifundo somqhubi. Isondlo Uphando 2003; 23: 1189-1198.
49. IHosseini S, iPishnamazi S Sadrzadeh SMH Farid F Farid R Watson RR. IPycnogenol kulawulo lwesifuba. J Amayeza okutya 2001; 4: 201-209.
50. UDurackova, Z., Trebaticky, B., Novotny, V., Zitnanova, A., kunye noBreza, J. Lipid metabolism kunye nokuphuculwa kokungasebenzi kakuhle kwe-Pycnogenol (R), ekhutshwe kwixolo likaPinus pinaster kwizigulana ezinengxaki yokungasebenzi kakuhle. - isifundo somqhubi. Isondlo Res. Ngo-2003; 23: 1189-1198.
51. I-Kohama T, i-Negami M.Iziphumo zedosi esezantsi ye-French Maritime Pine Bark Extract kwi-Climacteric Syndrome kwi-170 ye-Perimenopausal Women: I-Randomised, Double-blind, Placebo-controlled Trial. J wokuZala kwakhona ngo-2013; 58: 39-47.
52. I-Schmidtke I, Schoop W. Pycnogenol: i-stasis edema kunye nonyango lwayo. ISchweizerische Zeitschrift fur GanzheitsMedizin 1995; 3: 114-115.
53. IHosseini, S., Lee, J., Sepulveda, RT, Fagan, T., Rohdewald, P., kunye noWatson, RR Uvavanyo olungahleliwe, oluyimfama kabini, olulawulwa yi-placebo, olunokufundwa ngeeveki ezili-16 zokufunda indima yePycnogenol (R ) ekuhlengahlengiseni uxinzelelo lwegazi kwizigulana ezinesifo esiphezulu. Isondlo Res. 2001; 21: 67-76.
54. U-Wang S, uTan D Zhao Y okqhubekayo. Iziphumo zepycnogenol kwi-microcirculation, platelet function kunye ne-ischemic myocardium kwizigulana ezinesifo semithambo. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 19-25.
55. I-Wei, Z., Peng, Q., kunye neLau, B.I-Pycnogenol iphucula ukhuseleko lwe-endothelial cell antioxidant. Ingxelo yeRedox 1997; 3: 219-224.
56. IVirgili, F., Kobuchi, H., kunye nePacker, L.Procyanidins ekhutshwe kwiPinus maritima (Pycnogenol): abahlaseli bezilwanyana zasimahla kunye neemodyuli ze-nitrogen monoxide metabolism kwi-murine RAW 264.7 macrophages. Radic yasimahla. Biol Med 1998; 24 (7-8): 1120-1129. Jonga i-abstract.
57. IMacrides, T. A., Shihata, A., Kalafatis, N., kunye neWright, P. F. Thelekisa iipropathi ze-hydroxyl radical scavenging ze-shark bile steroid 5 beta-scymnol kunye ne-pycnogenols yezityalo. I-Biochem Mol Biol Int 1997; 42: 1249-1260. Jonga i-abstract.
58. UNoda, Y., Anzai, K., Mori, A., Kohno, M., Shinmei, M., kunye noPacker, L.Hydroxyl kunye ne-superoxide anion imisebenzi yokuqhekeza imithombo yendalo ye-antioxidants isebenzisa inkqubo ye-YES-FR30 ESR yekhompyuter . I-Biochem Mol Biol Int 1997; 42: 35-44. Jonga i-abstract.
59. UFurumura, M., Sato, N., Kusaba, N., Takagaki, K., kunye noNakayama, J.Ukulawulwa ngomlomo kwefrench maritime pine bark extract (Flavangenol ((R))) kuphucula iimpawu zeklinikhi kulusu lobuso olunemifanekiso. Iiklinikhi, ukuguga ngo-2012; 7: 275-286. Jonga i-abstract.
60. I-Perera, N., Liolitsa, D., Iype, S., Croxford, A., Yassin, M., Lang, P., Ukaegbu, O., kunye ne-van, i-Issum C. I-Phlebotonics ye-haemorrhoids. Idatha yedatha yeCochrane. Ngo-2012; 8: CD004322. Jonga i-abstract.
61. I-Schoonees, A., Visser, J., Musekiwa, A., kunye neVolmink, J. Pycnogenol (R) (ukukhutshwa kwe-French bark pine bark) kunyango lweengxaki ezingapheliyo. Idatha yedatha yeCochrane. Ngo-2012; 4: CD008294. Jonga i-abstract.
62. I-Schoonees, A., Visser, J., Musekiwa, A., kunye neVolmink, J. Pycnogenol ((R)) kunyango lwezifo ezingapheliyo. Idatha yedatha yeCochrane. Ngo-2012; 2: CD008294. Jonga i-abstract.
63. Marini, A., Grether-Beck, S., Jaenicke, T., Weber, M., Burki, C., Formann, P., Brenden, H., Schonlau, F., kunye noKcutmann, uJ. Pycnogenol (R Iziphumo ekuthambekeni kolusu kunye ne-hydration zihambelana nokwanda kohlobo lwe-collagen uhlobo I kunye ne-hyaluronic acid synthase kwabasetyhini. Ulusu lwePhemacol. IPhysol 2012; 25: 86-92. Jonga i-abstract.
64. IMach, J., Midgley, A. W., Dank, S., Grant, R. S., kunye neBentley, D. J. Iziphumo zokuncedisa i-antioxidant ekunciphiseni ukudinwa ngexesha lokuzilolonga: indima enokubakho yeNAD + (H). Izondlo. Ngo-2010; 2: 319-329. Jonga i-abstract.
65. U-Enseleit, F., Sudano, I., Periat, D., Winnik, S., Wolfrum, M., Flammer, AJ, Frohlich, GM, Kaiser, P., Hirt, A., Haile, SR, Krasniqi, N ., Matter, CM, Uhlenhut, K., Hogger, P., Neidhart, M., Luscher, TF, Ruschitzka, F., and Noll, G. Iziphumo zePycnogenol ekusebenzeni kwe-endothelial kwizigulana ezinesifo somthambo ozinzileyo: a. -imfama ezimbini, ezilawulwa ngokungekho mthethweni, ezilawulwa yi-placebo. Intliziyo J. 2012; 33: 1589-1597. Jonga i-abstract.
66. ILuzzi, R., Belcaro, G., Zulli, C., Cesarone, MR, Cornelli, U., Dugall, M., Hosoi, M., kunye noFeragalli, B.Ukuncediswa kwePycnogenol (R) kuphucula ukusebenza kwengqondo, ingqalelo kunye ukusebenza kwengqondo kubafundi. IPanminerva Med. Ngo-2011; 53 (3 iSuppl 1): 75-82. Jonga i-abstract.
67. Errichi, S., Bottari, A., Belcaro, G., Cesarone, MR, Hosoi, M., Cornelli, U., Dugall, M., Ledda, A., noFeragalli, B. Ukongezwa kunye nePycnogenol (R) phucula imiqondiso kunye neempawu zotshintsho lwe-menopausal. IPanminerva Med. 2011; 53 (3 Inkxaso 1): 65-70. Jonga i-abstract.
68. IBelcaro, G., Luzzi, R., Cesinaro Di, Rocco P., Cesarone, MR, Dugall, M., Feragalli, B., Errichi, BM, Ippolito, E., Grossi, MG, Hosoi, M., Errichi. , S., Cornelli, U., Ledda, A., kunye noGizzi, G. Pycnogenol (R) uphuculo kulawulo lwesifuba. IPanminerva Med. 2011; 53 (3 Inkxaso 1): 57-64. Jonga i-abstract.
69. U-Errichi, BM, Belcaro, G., Hosoi, M., Cesarone, MR, Dugall, M., Feragalli, B., Bavera, P., Hosoi, M., Zulli, C., Corsi, M., Ledda, A., Luzzi, R., kunye noRicci, A. Uthintelo lwe-post thrombotic syndrome kunye nePycnogenol (R) kwisifundo seenyanga ezilishumi elinambini. IPanminerva Med. 2011; 53 (3 Inkxaso 1): 21-27. Jonga i-abstract.
70. UAoki, H., Nagao, J., Ueda, T., Strong, JM, Schonlau, F., Yu-Jing, S., Lu, Y., kunye noHorie, S. Uvavanyo lwezonyango lwesongezelelo sePycnogenol (R ) kunye ne-L-arginine kwizigulana zaseJapan ezinesidima ukuya kwimodareyitha yokungasebenzi kakuhle. Phytother.Res. Ngo-2012; 26: 204-207. Jonga i-abstract.
71. I-Ohkita, M., Kiso, Y., kunye neMatsumura, Y. Pharmacology kukutya kwezempilo: ukuphuculwa komsebenzi we-vascular endothelial yi-French maritime pine bark extract (Flavangenol). UJ. Pharmacol. Inzululwazi. Ngo-2011; 115: 461-465. Jonga i-abstract.
72. UDvorakova, M., Paduchova, Z., Muchova, J., Durackova, Z., kunye noCollins, A. R. Ingaba i-pycnogenol (R) iwuchaphazela njani umonakalo we-oxidative kwi-DNA nakwimeko yayo yokulungisa kubantu abadala? Prague.Med.Rep. Ngo-2010; 111: 263-271. Jonga i-abstract.
73. UHenrotin, Y., uLambert, C., uCouchourel, D., uRipoll, uC, noChiotelli, uE. Nutraceuticals: ngaba bamele ixesha elitsha kulawulo lwe-osteoarthritis? -Uphononongo olubalisayo kwizifundo ezithathwe kwiimveliso ezintlanu. I-Osteoarthritis. Ngo-2011; 19: 1-21. Jonga i-abstract.
74. Pavone, C., Abbadessa, D., Tarantino, M. L., Oxenius, I., Lagana, A., Lupo, A., kunye noRinella, M. [Ukudibanisa iSerenoa repens, Urtica dioica kunye nePinus pinaster. Ukhuseleko kunye nokusebenza kunyango lweempawu ezisezantsi zomchamo. Ufundo olulindelekileyo kwizigulana ezingama-320]. Urologia. Ngo-2010; 77: 43-51. Jonga i-abstract.
75. Drieling, R. L., Gardner, C. D., Ma, J., Ahn, D. K., kunye no-Stafford, R. S. Akukho ziphumo ziluncedo zokukhupha i-pine bark kwisifo sentliziyo. IArch Ingaphakathi. 9-27-2010; 170: 1541-1547. Jonga i-abstract.
76. Reuter, J., Wolfle, U., Korting, H. C., kunye neSchempp, C. Sesiphi isityalo sesiphi isifo solusu? Icandelo 2: I-Dermatophytes, ukungabikho komzimba okungapheliyo, ukukhusela i-photoprotection, i-actinic keratoses, i-vitiligo, ukulahleka kweenwele, izibonakaliso zezimonyo UJDtsch, iDermatol, iiGes. Ngo-2010; 8: 866-873. Jonga i-abstract.
77. Grossi, MG, Belcaro, G., Cesarone, MR, Dugall, M., Hosoi, M., Cacchio, M., Ippolito, E., kunye neBavera, P. Ukuphuculwa kokuhamba kwe-cochlear kunye nePycnogenol (R) kwizigulana ezine tinnitus: uvavanyo lokulinga. IPanminerva Med. 2010; 52 (2 iSuppl 1): 63-67. Jonga i-abstract.
78. Stuard, S., Belcaro, G., Cesarone, MR, Ricci, A., Dugall, M., Cornelli, U., Gizzi, G., Pellegrini, L., kunye noRohdewald, PJ ukusebenza kwezintso kwisifo se-metabolic syndrome kunokuba iphuculwe ngePycnogenol (R). IPanminerva Med. 2010; 52 (2 iSuppl 1): 27-32. Jonga i-abstract.
79. UCesarone, uM.R., Belcaro, G., Rohdewald, P., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Ippolito, E., Fano, F., Dugall, M., Cacchio, kunye noF. M., Di, Renzo A., Hosoi, M., Stuard, S., kunye noCorsi, M. Ukuphuculwa kweempawu kunye neempawu zokungoneliseki kwe-venous insufficiency kunye ne-microangiopathy kunye nePycnogenol: isifundo esiza kubakho, esilawulwayo. Unyango lwezonyango. Ngo-2010; 17: 835-839. Jonga i-abstract.
80. UCesarone, MR, Belcaro, G., Stuard, S., Schonlau, F., Di, Renzo A., Grossi, MG, Dugall, M., Cornelli, U., Cacchio, M., Gizzi, G., kunye Pellegrini, L.Ukuhamba kwezintso kunye nokusebenza koxinzelelo lwegazi: Iziphumo ezikhuselayo zepycnogenol kubathathi-nxaxheba abanesifo soxinzelelo-isifundo esilawulwayo. UJ. Cardiovasc, iPharmacol, uTher. Ngo-2010; 15: 41-46. Jonga i-abstract.
81. UBelcaro, G., Cesarone, MR, Errichi, B., Di, Renzo A., Grossi, MG, Ricci, A., Dugall, M., Cornelli, U., Cacchio, M., kunye noRohdewald, P. Pycnogenol Unyango lweziqendu ezibukhali ze-hemorrhoidal. Phytother.Res. Ngo-2010; 24: 438-444. Jonga i-abstract.
82. Steigerwalt, R., Belcaro, G., Cesarone, MR, Di, Renzo A., Grossi, MG, Ricci, A., Dugall, M., Cacchio, M., kunye no Schonlau, F. Pycnogenol iphucula i-microcirculation, retinal edema , kunye nokubonakala kwamehlo kwisifo seswekile sokuqala. J. Ocul, iParmacol kunye noTher. Ngo-2009; 25: 537-540. Jonga i-abstract.
83. IBelcaro, G., Cesarone, M., Silvia, E., Ledda, A., Stuard, S., GV, Dougall, M., Cornelli, U., Hastings, C., kunye noSchonlau, F. Ukusetyenziswa kwemihla ngemihla I-Reliv Glucaffect yeeveki ze-8 yehlise kakhulu iswekile yegazi kunye nobunzima bomzimba kwizifundo ezingama-50. Phytother.Res. 4-29-2009; Jonga i-abstract.
84. URucklidge, J., Johnstone, J., kunye noKaplan, B. J. Izongezo zendlela yokunyanga i-ADHD. Ingcali. UMfu. Omnye. Ngo-2009; 9: 461-476. Jonga i-abstract.
85. UZibadi, S., Rohdewald, P. J., Park, D., kunye noWatson, R. R. Ukuncitshiswa kwemeko yomngcipheko wentliziyo kwizifundo ezinesifo seswekile sesi-2 ngokuxhaswa kwePycnogenol. Isondlo Res. Ngo-2008; 28: 315-320. Jonga i-abstract.
86. UBelcaro, G., Cesarone, MR, Errichi, S., Zulli, C., Errichi, BM, uVinciguerra, G., uLedda, A., uDi Renzo, A., uStuard, uS., UDugall, uM, uPellegrini. , L., Gizzi, G., Ippolito, E., Ricci, A., Cacchio, M., Cipollone, G., Ruffini, I., Fano, F., Hosoi, M., kunye noRohdewald, P. Umahluko kwi-C-protein esebenzayo, iplasma radicals kunye nexabiso le-fibrinogen kwizigulana ezine-osteoarthritis ephathwe ngePycnogenol. Redox. Ngo-2008; 13: 271-276. Jonga i-abstract.
87. URyan, J., Croft, K., Mori, T., Wesnes, K., Spong, J., Downey, L., Kure, C., Lloyd, J., kunye noStough, C. Uvavanyo lweziphumo ye-antioxidant Pycnogenol ekusebenzeni kwengqondo, iprofayili ye-serum lipid, i-endocrinological kunye ne-oxidative uxinzelelo lwe-biomarkers kubantu abadala. J Psychopharmacol. Ngo-2008; 22: 553-562. Jonga i-abstract.
88. UCisar, P., Jany, R., Waczulikova, I., Sumegova, K., Muchova, J., Vojtassak, J., Durackova, Z., Lisy, M., noRohdewald, P. Iziphumo zokukhupha i-pine bark (Pycnogenol) kwiimpawu zedolo osteoarthritis. Phytother.Res. Ngo-2008; 22: 1087-1092. Jonga i-abstract.
89. USuzuki, N., Uebaba, K., Kohama, T., Moniwa, N., Kanayama, N., kunye noKoike, K. Umdaka wasepayini waselwandle waseFrance ukhupha kakhulu kunciphisa imfuno yamayeza e-analgesic kwi-dysmenorrhea: i-multicenter, i-randomized, Uphononongo olulawulwa kabini, olulawulwa yi-placebo. J Uyaziphindezela. Ngo-2008; 53: 338-346. Jonga i-abstract.
90. UBelcaro, G., Cesarone, MR, Errichi, S., Zulli, C., Errichi, BM, uVinciguerra, G., uLedda, A., uDi Renzo, A., uStuard, uS., UDugall, uM, uPellegrini. , L., Errichi, S., Gizzi, G., Ippolito, E., Ricci, A., Cacchio, M., Cipollone, G., Ruffini, I., Fano, F., Hosoi, M., kunye URohdewald, P. Unyango lwe-osteoarthritis kunye nePycnogenol. I-SVOS (iSifundo seSan Valentino Osteo-arthrosis). Uvavanyo lweempawu, iimpawu, ukusebenza komzimba kunye nemiba yeethambo. Phytother.Res. Ngo-2008; 22: 518-523. Jonga i-abstract.
91. UDvorakova, M., Jezova, D., Blazicek, P., Trebaticka, J., Skodacek, I., Suba, J., Iveta, W., Rohdewald, P., kunye noDurackova, Z.Iiketekhamines zomchamo kubantwana abane Ingqwalaselo yokusilela kokuphazamiseka kwengqondo (ADHD): ukumodareyithwa sisicatshulwa se-polyphenolic kwi-pine bark (pycnogenol). Isondlo. Ngo-2007; 10 (3-4): 151-157. Jonga i-abstract.
92. UNikolova, V., Stanislavov, R., Vatev, I., Nalbanski, B., kunye noPunevska, M. [Iiparamitha zesidoda kwinzala yamadoda emva konyango nge-prelox]. IGinekol. (Sofiia) 2007; 46: 7-12. Jonga i-abstract.
93. UCesarone, MR, Belcaro, G., Rohdewald, P., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Gizzi, G., Ippolito, E., Fano, F., Dugall. , M., Acerbi, G., Cacchio, M., Di Renzo, A., Hosoi, M., Stuard, S., kunye noCorsi, M. Uncedo olukhawulezileyo lweempawu / iimpawu kwi-microangiopathy engapheliyo kunye ne-pycnogenol: , isifundo esilawulwayo. I-Angiology 2006; 57: 569-576. Jonga i-abstract.
94. Chovanova, Z., Muchova, J., Sivonova, M., Dvorakova, M., Zitnanova, I., Waczulikova, I., Trebaticka, J., Skodacek, I., noDurackova, Z. Iziphumo zokukhutshwa kwe-polyphenolic, IPycnogenol, kwinqanaba le-8-oxoguanine kubantwana abanengxaki yokusilela / yokuphazamiseka kwengqondo. Radic yasimahla 2006; 40: 1003-1010. Jonga i-abstract.
95. UDvorakova, M., Sivonova, M., Trebaticka, J., Skodacek, I., Waczulikova, I., Muchova, J., noDurackova, Z. Iziphumo zokukhutshwa kwe-polyphenolic kwi-bark yepine, iPycnogenol kwinqanaba le-glutathione kubantwana abanengxaki yokuphazamiseka kwengqondo (ADHD). Redox. Ngo-2006; 11: 163-172. Jonga i-abstract.
96. UVoss, P., Horakova, L., Jakstadt, M., Kiekebusch, D., kunye noGrune, T. Ferritin oxidation kunye neproteasomal degradation: protection by antioxidants. Radic yasimahla, 2006; 40: 673-683. Jonga i-abstract.
97. IBelcaro, G., Cesarone, MR, Errichi, BM, Ledda, A., Di, Renzo A., Stuard, S., Dugall, M., Pellegrini, L., Gizzi, G., Rohdewald, P., Ippolito. , E., Ricci, A., Cacchio, M., Cipollone, G., Ruffini, I., Fano, F., noHosoi, M. Isifo seswekile sezilonda: ukuphuculwa kwe-microcirculatory kunye nokuphilisa ngokukhawuleza nge-pycnogenol. Iiklinikhi. Ngo-2006; 12: 318-323. Jonga i-abstract.
98. Ahn, J., Grun, I. U., kunye noMustapha, A. Iziphumo zezicatshulwa zezityalo ekukhuleni kwentsholongwane, ukutshintsha kombala, kunye ne-lipid oxidation kwinyama yenkomo ephekiweyo. Ukutya kweMicrobiol. Ngo-2007; 24: 7-14. Jonga i-abstract.
99. Grimm, T., Skrabala, R., Chovanova, Z., Muchova, J., Sumegova, K., Liptakova, A., Durackova, Z., kunye noHogger, P. I-single kunye ne-pharmacokinetics yedosi ye-pine marine ekhutshwe. (pycnogenol) emva kolawulo lomlomo kumavolontiya asempilweni. I-BMC yeClin Pharmacol 2006; 6: 4. Jonga i-abstract.
100. UCesarone, MR, Belcaro, G., Rohdewald, P., Pellegrini, L., Ledda, A., Vinciguerra, G., Ricci, A., Gizzi, G., Ippolito, E., Fano, F., Dugall. , M., Acerbi, G., Cacchio, M., Di Renzo, A., Hosoi, M., Stuard, S., kunye noCorsi, M. Ukuthelekiswa kwePycnogenol kunye neDaflon ekuphatheni ukungoneliseki okungapheliyo: okunokwenzeka, okulawulwayo ukufunda. Iiklinikhi ye-Appl Thromb. Ngo-2006; 12: 205-212. Jonga i-abstract.
101. UTrebaticka, J., Kopasova, S., Hradecna, Z., Cinovsky, K., Skodacek, I., Suba, J., Muchova, J., Zitnanova, I., Waczulikova, I., uRohdewald, P.,. kunye noDurackova, Z. Unyango lwe-ADHD ngesiFrentshi solwandle ikhupha i-bark, iPycnogenol. Umntwana ofikisayo kwi-Psychiatry 2006; 15: 329-335. Jonga i-abstract.
102. I-Chayasirisobhon, S. Ukusetyenziswa kwe-pine bark isicatshulwa kunye nemveliso ye-antioxidant ye-vitamin yokudibanisa njengonyango lwe-migraine kwizigulana ezinganyangekiyo kunyango lwe-pharmacologic. Intloko ye2006; 46: 788-793. Jonga i-abstract.
103. Grimm, T., Chovanova, Z., Muchova, J., Sumegova, K., Liptakova, A., Durackova, Z., kunye noHogger, P. Ukuthintela ukwenziwa kwe-NF-kappaB kunye nemfihlo ye-MMP-9 yi-plasma yomntu. amavolontiya emva kokungenisa isicatshulwa sepine marine (Pycnogenol). J Ukudumba. (Isidenge) 2006; 3: 1. Jonga i-abstract.
104. Schafer, A., Chovanova, Z., Muchova, J., Sumegova, K., Liptakova, A., Durackova, Z., kunye noHogger, P. Ukuthintelwa kwe-COX-1 kunye ne-COX-2 yomsebenzi ngeplasma yamavolontiya abantu. emva kokungenisa isicatshulwa sepine marine sasemanzini (Pycnogenol). Utshilo. Ngo-2006; 60: 5-9. Jonga i-abstract.
105. UBelcaro, G., Cesarone, MR, Errichi, BM, Ledda, A., Di Renzo, A., Stuard, S., Dugall, M., Pellegrini, L., Rohdewald, P., Ippolito, E., Ricci. , A., Cacchio, M., Ruffini, I., Fano, F., noHosoi, M. Izilonda ezinemithambo-luvo: ukuphuculwa kombane kunye nokunyanga ngokukhawuleza ngokusetyenziswa kwePycnogenol kwalapha ekhaya. I-Angiology 2005; 56: 699-705. Jonga i-abstract.
106. IBaumann, L. Uyikhusela njani ifoto? J Tyala iDermatol. 2005; 125: xii-xiii. Jonga i-abstract.
107. UTorras, M.A., Faura, C. A., Schonlau, F., kunye noRohdewald, P. Umsebenzi weAntimicrobial wePycnogenol. UPhytother Res 2005; 19: 647-648. Jonga i-abstract.
108. I-Thornfeldt, C. iiCosmeceuticals ezinamayeza: inyani, ubuxoki, kunye nekamva. Indawo yesikhumba. 2005; 31 (7 Pt 2): 873-880. Jonga i-abstract.
109. UCesarone, MR, Belcaro, G., Rohdewald, P., Pellegrini, L., Ippolito, E., Scoccianti, M., Ricci, A., Dugall, M., Cacchio, M., Ruffini, I., Fano , F., Acerbi, G., Vinciguerra, MG, Bavera, P., Di Renzo, A., Errichi, BM, kunye noMucci, F. Uthintelo lwe-edema kwiinqwelomoya ezinde kunye nePycnogenol. Iiklinikhi Appl. Ingcango. Ngo-2005; 11: 289-294. Jonga i-abstract.
110. U-Huang, W. W., Yang, J. S., Lin, C. F., Ho, W. J., kunye no-Lee, M. R. Pycnogenol yenza ukuba umahluko kunye ne-apoptosis kwi-promyeloid leukemia HL-60 iiseli. Leuk. 2005; 29: 685-692. Jonga i-abstract.
111. I-Segger, D. kunye ne-Schonlau, F. Ukongezwa kunye no-Evelle kuphucula ukutyibilika kolusu kunye nokuqina kwisifundo esilawulwa yimfama, esilawulwa yi-placebo kunye nabafazi abangama-62. J Dermatolog. Unyango. Ngo-2004; 15: 222-226. Jonga i-abstract.
112. UMochizuki, M. kunye noHasegawa, N. I-Pycnogenol ivuselela i-lipolysis kwiiseli ze-3t3-L1 ngokukhuthaza ukusebenza kwe-beta-receptor. UPhytother Res 2004; 18: 1029-1030. Jonga i-abstract.
113. I-Mochizuki, M. kunye neHasegawa, N. Ukusebenza ngokunyanga kwe-pycnogenol kwizifo zesilingo sokudumba. UPhytother Res 2004; 18: 1027-1028. Jonga i-abstract.
114. UDene, B. A., Maritim, A. C., Sanders, R. A., kunye noWatkins, J. B., III. Iziphumo zonyango lwe-antioxidant kwizinto eziqhelekileyo nakwizinto ezineswekile kwimisebenzi ye-enzyme ye-retinal enzyme. J Ocul. Pharmacol Ther 2005; 21: 28-35. Jonga i-abstract.
115. Berryman, A. M., Maritim, A. C., Sanders, R. A., kunye noWatkins, J. B., III. Impembelelo yonyango lwesifo seswekile ngokudibanisa i-pycnogenol, i-beta-carotene, kunye ne-alpha-lipoic acid kwiiparameter zoxinzelelo lwe-oxidative. J Biochem Mol Toxicol 2004; 18: 345-352 (PubMed) (Umnqamlezo) Jonga i-abstract.
116. UNelson, A. B., Lau, B. H., Ide, N., kunye noRong, Y. I-Pycnogenol inqanda ukuqhuma kwe-macrophage oxidative, i-lipoprotein oxidation, kunye ne-hydroxyl eyenze umonakalo omkhulu we-DNA. Isiyobisi seDr. Ind Pharm 1998; 24: 139-144. Jonga i-abstract.
117. I-Kim, i-Y. Kunye nePaki, i-HY Iziphumo zePycnogenol kumonakalo we-DNA kwi-vitro kunye nokubonakaliswa kwe-superoxide dismutase kunye ne-HP1 kwi-Escherichia coli SOD kunye neeseli ezingenasiphelo ze-catalase. Umzimba weRes 2004; 18: 900-905. Jonga i-abstract.
118. UBelcaro, G., Cesarone, MR, Rohdewald, P., Ricci, A., Ippolito, E., Dugall, M., Griffin, M., Ruffini, I., Acerbi, G., uVinciguerra, uMG, uBhavera, P., Di Renzo, A., Errichi, BM, kunye noCerritelli, F. Uthintelo lwe-venous thrombosis kunye ne-thrombophlebitis kwiinqwelomoya ezinde kunye ne-pycnogenol. Iiklinikhi Appl. Ingcango. Ngo-2004; 10: 373-377. Jonga i-abstract.
119. I-Siler-Marsiglio, K. I., Paiva, M., Madorsky, I., Serrano, Y., Neeley, A., kunye neHeaton, M. B. Iindlela zokukhusela i-pycnogenol kwiiseli ze-cerebellar ze-granule ezihlambalazayo. J Neurobiol. Ngo-2004; 61: 267-276. Jonga i-abstract.
120. Ahn, J., Grun, I. U., kunye no-Mustapha, A. Imisebenzi ye-Antimicrobial kunye ne-antioxidant yezicatshulwa zendalo kwi-vitro nakwinyama yenyama. J Prot Prot. Ngo-2004; 67: 148-155. Jonga i-abstract.
121. Liu, X., Wei, J., Tan, F., Zhou, S., Wurthwein, G., kunye noRohdewald, P. Pycnogenol, i-French maritime pine bark extract, iphucula ukusebenza kwe-endothelial yezigulana ezixinzelelekileyo. Ubomi beSayensi 1-2-2004; 74: 855-862. Jonga i-abstract.
122. UZhang, D., Tao, Y., Gao, J., Zhang, C., Wan, S., Chen, Y., Huang, X., Ilanga, X., uDuan, S., uSchonlau, uF. URohdewald, P., kunye noZhao, B. I-Pycnogenol kwiifilitha zecuba zigxotha ii-radicals zasimahla kwaye zinciphise ukungabinamandla kunye netyhefu yomsi wecuba kwi-vivo. I-Toxicol Ind yezeMpilo 2002; 18: 215-224. Jonga i-abstract.
123. IMaritim, A., Dene, B. A., Sanders, R. A., kunye neWatkins, J. B., III. Iziphumo zonyango lwe-pycnogenol kuxinzelelo lwe-oxidative kwi-streptozotocin-indened diabetic rats. J Ubuchwephesha Mol Toxicol 2003; 17: 193-199. Jonga i-abstract.
124. IHosseini, S., Pishnamazi, S., Sadrzadeh, S. M., Farid, F., Farid, R., kunye noWatson, R. R. Pycnogenol ((R)) kuLawulo lwe-Asthma. J Med Ukutya 2001; 4: 201-209. Jonga i-abstract.
125. I-Sharma, S. C., Sharma, S., kunye neGulati, O. P. I-Pycnogenol inqanda ukukhutshwa kwe-histamine kwiiseli zemasti. UPhytother Res 2003; 17: 66-69. Jonga i-abstract.
126. UDevaraj, S., Vega-Lopez, S., Kaul, N., Schonlau, F., Rohdewald, P., kunye noJialal, I. Ukongezwa kunye ne-pine bark ekhutshwe isityebi kwi-polyphenols kwandisa amandla e-plasma antioxidant kwaye iguqula iplasma lipoprotein iprofayile. IiLipids 2002; 37: 931-934. Jonga i-abstract.
127. URoseff, S. J. Uphuculo kumgangatho wesidoda kunye nokusebenza kwe-French maritime pine tree bark extract. J Ukuphindezela Med 2002; 47: 821-824. Jonga i-abstract.
128. Ni, Z., Mu, Y., kunye noGulati, O. Unyango lwe-melasma kunye nePycnogenol. Phytother.Res. Ngo-2002; 16: 567-571. Jonga i-abstract.
129. I-Kimbrough, C., Chun, M., dela, Roca G., kunye noLau, B. H. PYCNOGENOL ukuhlafuna itshungama kunciphisa ukuphuma kwegingival kunye nokwenziwa kwamacwecwe. Unyango 2002; 9: 410-413. Jonga i-abstract.
130. UPeng, Q. L., Buz'Zard, A. R., kunye noLau, B. H. Pycnogenol ikhusela ii-neurons kwi-apoptosis ye-amyloid-beta peptide. Ubunzima beBrain Res Mol Brain Res 7-15-2002; 104: 55-65. Jonga i-abstract.
131. Cho, K.J, Yun, C.H, Packer, L., kunye noChung, A. S. Iindlela zokuthintela i-bioflavonoids ethathwe kwi-bark yasePinus maritima ekubonakaliseni i-cytokines ezinamandla. UAnn N Y Acad Sci 2001; 928: 141-156. Jonga i-abstract.
132. UKim, H. C. noHealey, J. M. Iziphumo zokukhutshwa kwe-pine bark elawulwa kwiimpuku zabantu abadala ezingosulelwanga yi-Cryptosporidium parvum. NdinguJ Chin Med 2001; 29 (3-4): 469-475. Jonga i-abstract.
133. Stefanescu, M., Matache, C., Onu, A., Tanaseanu, S., Dragomir, C., Constantinescu, I., Schonlau, F., Rohdewald, P., kunye no-Szegli, G.Ukusebenza kwe-Pycnogenol kunyango yesigulana se-lupus erythematosus. UPhytother Res 2001; 15: 698-704. Jonga i-abstract.
134. Cho, KJ, Yun, CH, Yoon, DY, Cho, YS, Rimbach, G., Packer, L., kunye noChung, AS Iziphumo ze-bioflavonoids ezikhishwe kwi-bark yasePinus maritima kwimveliso ye-cytokine interleukin-1 kwimveliso ye-lipopolysaccharide- ivuselelwe iRAW 264.7. Ukusetyenziswa kwetyhefu. Pharmacol 10-1-2000; 168: 64-71. Jonga i-abstract.
135. UHuynh, H. kunye noTeel, R. W. Ukukhethwa kwe-apoptosis kwiiseli zomhlaza wamabele (MCF-7) yi-pycnogenol. I-Anticancer Res 2000; 20: 2417-2420. Jonga i-abstract.
136. I-Peng, Q., Wei, Z., kunye neLau, B. H. Pycnogenol inhibit tumor necrosis factor-alpha-indased nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells. Iseli yoBomi beSayensi yoBomi 2000; 57: 834-841. Jonga i-abstract.
137. I-Araghi-Niknam, M., Hosseini, S., Larson, D., Rohdewald, P., kunye noWatson, R. R.Ukukhonkotha i-Pine bark kunciphisa ukuhlanganiswa kweplatelet. Umdibaniso. 3-21-2000; 2: 73-77. Jonga i-abstract.
138. Moini, H., Arroyo, A., Vaya, J., kunye nePacker, L.Iziphumo zeBioflavonoid kwimetochondrial yokuphefumla ikhonkco yothutho kunye necytochrome c redox state. I-Redox. I-1999; 4 (1-2): 35-41. Jonga i-abstract.
139. I-Bors, W., Michel, C., kunye ne-Stettmaier, K. Electron paramagnetic resonance yezifundo zeentlobo ezigwenxa zeproanthocyanidins kunye ne-gallate esters. IArch Biochem Biophys. 2-15-2000; 374: 347-355. Jonga i-abstract.
140. I-Kobayashi, M. S., Han, D., kunye nePacker, L.I-Antioxidants kunye nezicatshulwa zemifuno zikhusela iiseli ze-HT-4 ze-neuronal ngokuchasene ne-cytotoxicity eyenziwe nge-glutamate. Radic yasimahla IRes 2000; 32: 115-124. Jonga i-abstract.
141. IHasegawa, N. Ukukhuthaza i-lipolysis yi-pycnogenol. UPhytother Res 1999; 13: 619-620. Jonga i-abstract.
142. I-Packer, L., Rimbach, G., kunye neVirgili, F. Umsebenzi we-Antioxidant kunye neempawu zebhayoloji yesichumisi esityebileyo se-procyanidin kwipine (Pinus maritima) bark, pycnogenol. Radic yasimahla. Biol Med 1999; 27 (5-6): 704-724. Jonga i-abstract.
143. Huynh, H.Teel, R. W. Iziphumo zokulawulwa kwe-intragastrically yiPycnogenol kwi-NNK metabolism kwiigundane ze-F344. I-Anticancer Res 1999; 19 (3A): 2095-2099. Jonga i-abstract.
144. Huynh, H.Teel, R. W. Iziphumo ze-pycnogenol kwimicrosomal metabolism ye-nitrosamine ye-nitrosamine ekhethekileyo ye-NNK njengomsebenzi wobudala. Umhlaza Lett 10-23-1998; 132 (1-2): 135-139. Jonga i-abstract.
145. Belcaro, G., Cesarone, MR, Dugall, M., Hosoi, M., Ippolito, E., Bavera, P., kunye noGrossi, Uphando lwe-MG lwePycnogenol (R) ngokudibeneyo necoenzymeQ10 kwizigulana ezingaphumeleli kwentliziyo (NYHA II / III). IPanminerva Med 2010; 52 (2 iSuppl 1): 21-25. Jonga i-abstract.
146. UClark, uC. E., uArnold, uE, uLasserson, uT. J., noWu, uT. Ungenelelo ngamayeza esifo sesifuba esinganyangekiyo kubantu abadala nasebantwaneni: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta. IPrim. YokuPhefumla kwakhona. J 2010; 19: 307-314. Jonga i-abstract.
147. Steigerwalt, R. D., Gianni, B., Paolo, M., Bombardelli, E., Burki, C., noSchonlau, F. Iziphumo zeMirtogenol ekuhambeni kwegazi nge-ocular kunye noxinzelelo lwexinzelelo lwe-intraocular kwizifundo ze-asymptomatic. I-Mol Vis 2008; 14: 1288-1292. Jonga i-abstract.
148. ULedda, A., Belcaro, G., Cesarone, MR, Dugall, M., kunye noSchonlau, F.Uphando lwesityalo esintsonkothileyo sokuthomalalisa ukungasebenzi kakuhle kwe-erectile kulungelelwaniso, olulawulwa ngamehlo kabini ukufunda ngengalo. BJU.Int. 2010; 106: 1030-1033. Jonga i-abstract.
149. UStanislavov, R., uNikolova, V., kunye noRohdewald, P. Ukuphuculwa kweeparameter zeseminal kunye nePlox: ilingo elingenamkhethe, elingaboniyo, elilawulwa yi-placebo. Phytother. Res 2009, 23: 297-302. Jonga i-abstract.
150. UWilson D, uEvans M, uGuthrie N et al. Uphononongo lokuhlola olulawulwa ngokungahleliwe, oluyimfama, olulawulwa yi-placebo ukuvavanya amandla e-pycnogenol ekuphuculeni iimpawu ze-rhinitis. UPhytother Res 2010; 24: 1115-9. Jonga i-abstract.
151. UBelcaro G, uCesarone MR, uRicci A, et al. Isikhokelo soPhando Ukulawulwa kwe-edema kwizifundo ezixinzelelekileyo eziphathwe nge-calcium antagonist (nifedipine) okanye i-angiotensin-eguqula i-enzyme inhibitors nge-pycnogenol. Iiklinikhi ze-Appl Thromb Hemost 2006; 12: 440-4. Jonga i-abstract.
152. UVinciguerra G, uBelcaro G, uCesarone MR, et al. Iikhramps kunye neentlungu zezihlunu: uthintelo kunye nePyconogenol kwizifundo eziqhelekileyo, abaguli abanesifo, iimbaleki, ii-claudicants kunye nakwisifo sikashukela esincinci. I-Angiology 2006; 57: 331-9. Jonga i-abstract.
153. UCesarone MR, uBelcaro G, uRohdewald P, et al. Ukuchaneka Ukuphuculwa kwesifo seswekile esincinci kunye nePycnogenol: Isifundo esinokwenzeka, esilawulwayo. I-Angiology 2006; 57: 431-6. Jonga i-abstract.
154. U-Liu X, u-Wei J, u-Tan F, kunye no-al. Iziphumo zeAntidiabetic zePycnogenol French maritime pine bark isicatshulwa kwizigulana ezinesifo seswekile II. Ubomi beSayensi 2004; 75: 2505-13. Jonga i-abstract.
155. U-Liu X, u-Zhou HJ kunye no-Rohdewald P.I-French maritime pine bark ikhupha i-pycnogenol dose-exhomekeke kwi-glucose esezantsi kuhlobo lwe-2 lwezigulana zeswekile (ileta). Unonophelo lweSwekile 2004; 27: 839. Jonga i-abstract.
156. U-Kohama T, u-Suzuki N, u-Ohno S, u-Inoue M.Ukusebenza ngokukuko kwe-French bark yolwandle ye-pine bark ekhutshwe kwi-dysmenorrhea: ulingo oluvulekileyo lweklinikhi. J Uhlaziyiweyo Med 2004; 49: 828-32. Jonga i-abstract.
157. U-Kohama T, Inoue M. Pycnogenol unciphisa iintlungu ezinxulumene nokukhulelwa. UPhytother Res 2006; 20: 232-4. Jonga i-abstract.
158. UBlazso G, uGabor M, uSchonlau F, uRohdewald P.Pycnogenol ukhawulezisa ukuphilisa amanxeba kunye nokunciphisa ukubola. UPhytother Res 2004; 18: 579-81. Jonga i-abstract.
159. UYang HM, uLiao MF, uZhu SY, et al. Uvavanyo olulawulwa ngokungahleliwe, oluyimfama kabini, olulawulwa yi-placebo kwisiphumo sePycnogenol kwisifo se-climacteric syndrome kubafazi be-peri-menopausal. I-Acta Obstet Gynecol Scand 2007; 86: 978-85. Jonga i-abstract.
160. ILau BH, iRiesen SK, iTruong KP, et al. IPycnogenol njengesihlomelo kulawulo lwesifuba somntwana. J Isifuba ngo-2004; 41: 825-32. Jonga i-abstract.
161. UCesarone MR, Belcaro G, uNicolaides AN, okqhubekayo. Uthintelo lwe-venous thrombosis kwiinqwelomoya ezinde kunye neFlite Tabs: I-LONFLIT-FLITE yolingo, olulawulwayo. I-Angiology 2003; 54: 531-9. Jonga i-abstract.
162. UDurackova Z, uTrebaticky B, uNovotny V, et al. I-Lipid metabolism kunye nokuphuculwa kokusebenza kwe-Pycnogenol, ukukhutshwa kwi-bark ye-Pinus pinaster kwizigulana ezinengxaki yokungasebenzi kakuhle kwe-erectile-isifundo somqhubi. Ukutya okuneNut 2003; 23: 1189-98 ..
163. UStanislavov R, uNikolova V. Unyango lokungasebenzi kakuhle kwe-erectile kunye ne-pycnogenol kunye ne-L-arginine. J Ukwabelana ngesondo ngomtshato Ther 2003; 29: 207-13 .. Jonga okungafakwanga.
164. IHosseini S, uLee J, iSepulveda RT, et al. Ukulawulwa okungahleliwe, okungaboniyo, okulawulwa yi-placebo, okuza kubakho, isifundo se-crossover seveki ezili-16 ukucacisa indima ye-pycnogenol ekuguquleni uxinzelelo lwegazi kwizigulane ezinobungozi. Ukutya okunesondlo 2001; 21: 1251-60.
165. I-Bito T, i-Roy S, i-Sen CK, i-Packer L. I-Pine bark ikhupha i-pycnogenol downregulates i-IFN-gamma-indased adhesion yeeseli ze-T kwi-keratinocytes zabantu ngokuthintela ukubonakaliswa kwe-ICAM-1. Radic Biol Med yasimahla 2000; 28: 219-27 .. Jonga i-abstract.
166. UVirgili F, uPagana G, uBourne L, et al. Ukukhutshwa kwe-asidi ye-Ferulic njengophawu lokusetyenziswa kwepayini yaselwandle yaseFrance (iPinus maritima). Radic Biol Med yasimahla 2000; 28: 1249-56 .. Jonga i-abstract.
167. I-Tenenbaum S, uPaull JC, u-Sparrow EP, et al. Thelekisa ulingelo lwePycnogenol kunye ne-methylphenidate kubantu abadala abane-Attention-Deficit / Hyperactivity Disorder (ADHD). J Atten Disord 2002; 6: 49-60 .. Jonga i-abstract.
168. IHasegawa N. Uthintelo lwe-lipogenesis yi-pycnogenol. UPhytother Res 2000; 14: 472-3. Jonga i-abstract.
169. U-Liu F, u-Lau BHS, u-Peng Q, u-Shah V. I-Pycnogenol ikhusela iiseli ze-endothelial ze-vascular kwingozi ye-beta-amyloid. I-Biol Pharm Bull 2000; 23: 735-7. Jonga i-abstract.
170. I-Virgili F, i-Kim D, i-Packer L.I-Procyanidins ekhutshwe kwi-pine bark ikhusela i-alpha-tocopherol kwi-ECV 304 endothelial seli ezicelwe umngeni yi-RAW 264.7 macrophages: indima ye-nitric oxide kunye ne-peroxynitrite. Iileta zeFEBS 1998; 431: 315-8. Jonga i-abstract.
171. Ipaki YC, Rimbach G, Saliou C, et al. Umsebenzi we-monomeric, dimeric, kunye ne-trimeric flavonoids kwimveliso engekho, i-TNF-alpha secretion, kunye ne-NF-KB-exhomekeke kwimfuza kwi-RAW 264.7 macrophages. Iileta zeFEBS 2000: 465; 93-7. Jonga i-abstract.
172. USaliou C, uRimbach G, uMolni H, uMcLaughlin L, uHosseini S, uLee J, et al. I-erythema yelanga ebangelwe lilanga eluswini lomntu kunye nenyukliya-kappa-b-exhomekeke kwimfuza kwi-keratinocytes imodareyithwa yi-French Maritime pine bark. I-Radic Biol Med yasimahla ngo-2001; 30: 154-60. Jonga i-abstract.
173. UCheshier JE, uArdestani-Kaboudanian S, uLiang B, et al. Ukuzikhusela kwi-immune yi-pycnogenol kwiimpuku ezenziwa nge-retrovirus okanye ezondla i-ethanol. Ubomi beSayensi 1996; 58: 87-96. Jonga i-abstract.
174. UJialal I, Devaraj S, Hirany S, et al. Iziphumo zokuxhaswa kwe-pycnogenol kwiimpawu zokukrala. Olunye unyango 2001; 7: S17.
175. U-Koch R.Ukuthelekisa isifundo se-venostatin kunye ne-pycnogenol kwisifo esinganyangekiyo semithambo. UPhytother Res 2002: 16: S1-S5. UPhytother Res 2002: 16: S1-S5. Jonga i-abstract.
176. UHeiman SW. IPycnogenol ye-ADHD? J Ndiyi-Acad yabantwana abakwishumi elivisayo kwi-Psychiatry 1999; 38: 357-8. Jonga i-abstract.
177. I-Ohnishi ST, i-Ohnishi T, i-Ogunmola GB. I-Sickle cell anemia: indlela enesondlo kwisifo seemolekyuli. Isondlo 2000; 16: 330-8. Jonga i-abstract.
178. IMensink RP, Katan MB. Uvavanyo lwezifo kunye nokuvavanywa kwesiphumo seoyile yomnquma kwi-serum iyonke kunye ne-cholesterol ye-HDL kumavolontiya asempilweni. I-Eur J yeklinikhi yeNutrig 1989; 43 iSuppl 2: 43-8. Jonga i-abstract.
179. UPutter M, uGrotemeyer KH, uWurthwein G, et al. Ukuthintela ukudityaniswa kweplatelet ngokudityaniswa yi-aspirin kunye ne-pycnogenol. I-Thromb Res 1999; 95: 155-61. Jonga i-abstract.
180. UDauer A, uMetzner P, uSchimmer O.Iproanthocyanidins evela kwi-bark yeHamamelis virginiana ibonisa iipropathi ze-antimutagenic ngokuchasene ne-nitroaromatic compounds. IPlanta Med 1998; 64: 324-7. Jonga i-abstract.
181. I-Fitzpatrick DF, i-Bing, i-Rohdewald P. Endothelium exhomekeke kwiziphumo ze-vascular zePycnogenol. J Cardiovasc Pharmacol 1998; 32: 509-15. Jonga i-abstract.
182. U-Liu FJ, uZhang YX, uLau BH. I-Pycnogenol yonyusa imisebenzi ye-immune kunye ne-haemopoietic kwiigundane ezikhawulezayo ze-senescence. Iseli yoBomi beSayensi ngo-1998; 54: 1168-72. Jonga i-abstract.
183. UTixier JM, et al. Ubungqina nge-vivo nakwi-vitro yezifundo ezibopha i-pycnogenols kwi-elastin zichaphazela izinga lokuthotywa yi-elastases. Biochem Pharmacol 1984; 33: 3933-9. Jonga i-abstract.
184. URoseff SJ, uGulati R. Ukuphuculwa komgangatho wesidoda yi-pycnogenol. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 33-6.
185. U-Kohama T, uSuzuki N. Unyango lwezifo zesifo se-gynecological kunye ne-pycnogenol. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 30-2.
186. I-Pavlovic P.Unyamezelo oluphuculweyo ngokusebenzisa ii-antioxidants. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 26-9.
187. UWang S, uTan D, uZhao Y, et al. Iziphumo zepycnogenol kwi-microcirculation, platelet function kunye ne-ischemic myocardium kwizigulana ezinesifo semithambo. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 19-25.
188. URohdewald P. Ukunciphisa umngcipheko wokubetha kwentliziyo kunye ne-infarction yentliziyo kunye ne-pycnogenol. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 14-18.
189. IGulati OP. IPycnogenol kukuphazamiseka kwemithambo-luvo: uphononongo. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 8-13.
190. URohdewald P. Bioavailability kunye imetabolism ye pycnogenol. I-Eur Bull Res Res iziyobisi ngo-1999; 7: 5-7.
191. UWatson RR. Ukuncitshiswa kwemeko yomngcipheko wesifo sentliziyo. I-CVR & R 1999; Isilimela: 326-9.
192. I-Spadea L, iBalestrazzi E.Unyango lwee-retinopathies ze-vascular kunye ne-pycnogenol. UPhytother Res 2001; 15: 219-23. Jonga i-abstract.
193. I-Schmidtke I, Schoop W. Pycnogenol: i-stasis edema kunye nonyango lwayo. ISchweizerische Zeitschrift fur GanzheitsMedizin 1995; 3: 114-5.
194. I-Petrassi C, i-Mastromarino A, i-Spartera C. I-Pycnogenol yokungabikho komzimba okungapheliyo. Unyango lwe-2000; 7: 383-8. Jonga i-abstract.
195. I-Arcangeli P. Pycnogenol kukungabikho komzimba okungapheliyo. UFitoterapia 2000; 71: 236-44. Jonga i-abstract.
196. Ilayisi-i-Evans CA, iPacker L, ii-eds. I-Flavonoids kwiMpilo kunye nezifo. IManhattan, NY: UMarcel Dekker, Inc., 1998.
197. Ipakethi L, Midori H, Toshikazu Y, ii-eds. Izibonelelo zokutya zeAntioxidant kwiMpilo yaBantu. ISan Diego: Icandelo leendaba, ngo-1999.
198. I-Grosse Duweler K, iRohdewald P.Ii-metabolites ze-Urinary zaselwandle zephayini zikhupha abantu. Ikhemesti 2000; 55: 364-8. Jonga i-abstract.
199. Foster S, uTyler VE. I-Herbal ethembekileyo yeTyler, 4th ed., IBinghamton, NY: I-Haworth Herbal Press, ngo-1999.
200. ISkyrme-Jones RA, O'Brien RC, Berry KL, Meredith IT. Ukongezwa kweVitamin E kuphucula ukusebenza kwe-endothelial kuhlobo I seswekile: isifundo esilawulwa ngokungahleliwe, esilawulwa yi-placebo. NdinguColl Cardiol 2000; 36: 94-102. Jonga i-abstract.
201. ICorrigan JJ Jr. Iingxaki zokuxinana ezinxulumene nevithamini E. NdinguJ Pediatr Hematol Oncol 1979; 1: 169-73. Jonga i-abstract.
202. Amasebe L, Amasebe M, uShaw S, uLieber CS. Ubudlelwane phakathi kotshintsho kwii-plasma amino acid kunye noxinzelelo kwizigulana ezinxilisayo. NdinguJ J Psychiatry 1984; 141: 1212-5. Jonga i-abstract.
203. Iziko lezeMpilo. Indima yeprotein kunye neeamino acid ekugcineni nasekunyuseni ukusebenza. IWashington, DC: ICandelo lezeMfundo kuZwelonke, 1999. Iyafumaneka apha: http://books.nap.edu/books/0309063469/html/309.html#pagetop
204. INewall CA, uAnderson LA, uPhilpson JD. Unyango ngamayeza esintu: Isikhokelo saBasebenzi bezeMpilo. ILondon, e-UK: Icandelo leendaba lonyango, ngo-1996.
205. UTyler VE. IiHerbs zoKhetho. I-Binghamton, NY: Imveliso yezeMveliso yezeMveliso, ngo-1994.
206. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.

Ukuhlaziywa kokugqibela-10/02/2020